Clinical Trial Update: Incretin-based Drugs and the Risk of Heart Failure

View source ↗

Summary

A CNODES observational study update examines whether incretin-based therapies for type 2 diabetes influence the risk of heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors
• GLP-1 receptor agonists
• Incretin-based drugs

Snippet

Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED